Clinical evaluation of add-on administration of flavoxate hydrochloride in nocturia patients resistant to an anticholinergic agent

Clinical evaluation of add-on administration of flavoxate hydrochloride in nocturia patients resistant to an anticholinergic agent - Clinical evaluation of add-on administration of flavoxate hydrochloride in nocturia patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009999

Enrollment

Registered

2013-02-12

Start date

2013-02-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nocturia

Interventions

flavoxate hydrochloride, 200 mg, one tablet, once a day before sleep

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. nocturia (more than two times) 2. anticholinergic agent administration more than 8 weeks

Exclusion criteria

Exclusion criteria: 1. obvious polyuria patients 2. patients with cancer

Design outcomes

Primary

Measure	Time frame
nocturia, Hours of undisturbed sleep, side effect	—

Countries

Japan

Contacts

Public ContactMinoru Miyazato

University of the Ryukyus Department of Urology

miyaz929@med.u-ryukyu.ac.jp098-895-1186

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026